£520.00

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States

Price data last checked 67 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 24 days • 24 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 31 January 2026 06 February 2026 12 February 2026 18 February 2026

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £520 Days at Price

Price Analysis

Most common price: £520 (24 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 24 days

Product Specifications
Format
paperback
ASIN
B0BLQW27XS
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in India
98% match

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in India

£515.00 12 Feb 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States
96% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States
96% match

The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States

£520.00 09 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
96% match

The 2023-2028 Outlook for Macular Degeneration Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
96% match

The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics

£795.00 11 Feb 2026
The 2023-2028 Outlook for Thyroid Gland Disorders in the United States
96% match

The 2023-2028 Outlook for Thyroid Gland Disorders in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in the United States
96% match

The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Animal Feed Enzymes in the United States
96% match

The 2023-2028 Outlook for Animal Feed Enzymes in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for End Stage Renal Diseases in the United States
96% match

The 2023-2028 Outlook for End Stage Renal Diseases in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Hormone Replacement Therapies in the United States
96% match

The 2023-2028 Outlook for Hormone Replacement Therapies in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026